Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Steroids May Increase Infection Risk in Patients with IgA Nephropathy

Lara C. Pullen, PhD  |  September 11, 2017

Treatment with oral methylprednisolone may be associated with an increased risk of serious adverse events, specifically infection, in patients with IgA nephropathy. Despite the five-times higher risk, study results also showed a three-times lower risk of kidney failure for the treatment group…

Filed under:Conditions Tagged with:CorticosteroidsIgA nephropathykidneykidney diseaseSteroid

High Prevalence of Kingella Kingae in Children with Joint Infections

Anne Harding  |  September 7, 2017

NEW YORK (Reuters Health)—Oropharyngeal carriage of Kingella kingae is strongly associated with osteoarticular infection in young children, a case-control study done from Canada and Switzerland shows. “Most of the kids who have osteoarticular infection with Kingella kingae will also have it in their throat, so if we do a throat swab, we can identify it…

Filed under:Conditions Tagged with:K. kingaeKingella kingaeoropharyngeal carriageosteoarticular infection

FDA Update: Biosiomilar to Adalimumab Receives FDA Approval

Michele B. Kaufman, PharmD, BCGP  |  September 6, 2017

The FDA has approved adalimumab-adbm, a biosimilar, to treat multiple chronic inflammatory diseases…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabadalimumab-adbmbaricitinibFDAFood and Drug AdministrationRheumatoid Arthritis (RA)U.S. Food and Drug Administration

ACR Opposes UnitedHealthCare’s Move to End Consultation Reimbursement

Carina Stanton  |  September 6, 2017

Effective for claims with dates of service on or after Oct. 1, 2017, UnitedHealthCare (UHC) plans to no longer reimburse consultation services represented by CPT codes 99241–99245 and 99251–99255. In lieu of a consultation services procedure code, UHC says it will “reimburse the appropriate evaluation and management (E/M) procedure code which describes the office visit,…

Filed under:Billing/CodingLegislation & Advocacy Tagged with:CPT codes 99241–99245 and 99251–99255reimbursement cutsUnitedHealthCare (UHC)

ACR/ARHP Makes Another Push to Repeal Medicare Therapy Caps

Gretchen Henkel  |  September 6, 2017

H.R. 807, Medicare Access to Rehabilitation Services Act of 2017, will be one of the key issues discussed when members of the ACR’s Government Affairs Committee (GAC) visit Capitol Hill Sept. 26 during the annual Advocates for Arthritis event. This bill—as well as its companion bill in the Senate, S. 253—is aimed at repealing the…

Filed under:Legislation & Advocacy Tagged with:Advocates for ArthritisH.R. 807Medicare Access to Rehabilitation Services Act of 2017Medicare therapy cap repeal

Why We Advocate to Certain Congressional Committees over Others

From the College  |  September 5, 2017

The U.S. Congress refers to the bicameral legislature, consisting of the 435 voting and six non-voting members of the House of Representatives and the 100 members of the Senate. When we visit D.C. or express our policy positions to Congress, our message would ideally reach every member. The ultimate goal is to reach all 541…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:committees of jurisdictionEducationEnergy and Commerce CommitteeLabor and Pensions (HELP)LobbyingSenate Committee on HealthSenate Finance CommitteeU.S. CongressWays and Means Committee

Tocilizumab Is Effective to Treat GCA

Lara C. Pullen, PhD  |  August 28, 2017

In a recent clinical trial, tocilizumab helped sustain glucocorticoid-free remission in patients with giant cell arteritis. Patients also received a prednisone taper, and 50% of tocilizumab-treated patients achieved prednisone-free remission and were less likely to experience disease flare compared with placebo…

Filed under:ConditionsDrug UpdatesVasculitis Tagged with:aortaGCAgiant cell arteritis (GCA)glucocorticoidprednisoneRemissiontocilizumab

How to Manage Pain & Treatment in Elderly Patients

Richard Quinn  |  August 25, 2017

Elderly patients have unique requirements with regard to treatment for pain, rheumatic disease and other ailments. Collaboration between rheumatologists, geriatricians and primary care physicians is essential to avoid unnecessary interventions and improve care for this patient population…

Filed under:Practice Support Tagged with:elderlygeriatricgeriatricspatient careTreatment

FDA Committee Recommends Tofacitinib Approval

Michele B. Kaufman, PharmD, BCGP  |  August 22, 2017

The FDA Arthritis Advisory Committee voted 10 to 1 to recommend approval of tofacitinib to treat psoriatic arthritis…

Filed under:ConditionsDrug UpdatesPsoriatic Arthritis Tagged with:BimekizumabFDAFood and Drug AdministrationPsoriasisPsoriatic ArthritisTofacitinib

Alendronate Decreases Hip Fracture Risk in Older Patients Using Oral Prednisolone

Lara C. Pullen, PhD  |  August 21, 2017

New research found that older patients on prednisolone who are also treated with alendronate experience a significantly lower risk of hip fracture. Alendronate use was also associated with a lower risk of death…

Filed under:Conditions Tagged with:alendronateelderlyFractureship fracturehip fracture riskprednisolone

  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • 178
  • 179
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences